Increased Dosing Interval of Mogamulizumab in Patients With CTCL by CheckRare Staff| Published on: Jul 20, 2026

Increased Dosing Interval of Mogamulizumab in Patients With CTCL by CheckRare Staff| Published on: Jul 20, 2026 Christiane Querfeld, MD, PhD, dermatologist and and Director, Multidisciplinary Cutaneous Lymphoma Program, Professor at the City of Hope National Medical Center and the Beckman Research Institute, discusses the results of a new drug trial that increased the dosing interval of mogamulizumab in patients with CTCL. https://checkrare.com/increased-dosing-interval-of-mogamulizumab-in-patients-with-ctcl/